| 267 | 9 | 101 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨临床常见的鸟-胞内分枝杆菌复合群(MAC)肺病和龟-脓肿分枝杆菌肺病患者的临床特点。方法:回顾性分析我院2008年1月-2017年12月收治的85例MAC肺病和92例龟-脓肿分支杆菌肺病患者的临床与影像资料、T淋巴细胞亚群和营养指标结果,旨在提高非结核分枝杆菌(NTM)肺病的治疗水平。结果:(1)龟-脓肿组患者外周血CD3+、CD4+、CD8~+T淋巴细胞明显低于MAC组,差异有统计学意义(P<0.05)。(2)临床症状无特异性,营养不良发生率高,分别为82.4%和73.9%;MAC患者年龄较龟-脓肿患者偏大,差异有统计学意义(P<0.05)。(3)影像表现:两组患者均容易侵犯多个肺野与合并支气管扩张,病灶范围在4个肺野以上例数、合并空洞数差异均无统计学意义(P>0.05)。结论:临床常见的MAC与龟-脓肿分支杆菌肺病患者均以呼吸道症状与营养不良为主要表现;多肺野侵犯与空洞形成为特征的结构性肺病以及细胞免疫损伤可考虑为长期反复的支气管扩张并NTM感染的致病结果。
Abstract:Objective:To investigate the clinical features of pulmonary infections with Mycobacterium avium-intracellulare Complex(MAIC) and Mycobacterium chelonae-abscessus complex(MCAC), two clinically common lung diseases. Methods:A retrospective analysis was performed on clinical and imaging data, T lymphocyte subsets and nutritional indicators among 85 patients with MAIC lung disease and 92 with MCAC lung disease treated in our hospital between January 2008 and December 2017, aiming at improving our management of non-tuberculous mycobacteria(NTM) lung disease. Results:(1) The peripheral blood CD3+, CD4+ and CD8+ T lymphocytes in the MCIC group were significantly lower than those in the MCAC group, with statistically significant differences(P<0.05).(2) In these patients, the clinical symptoms were non-specific, and incidence rate of malnutrition was fairly high(82.4% and 73.9%, respectively). The patient age in the MAIC group was elder compared with the MCAC group, with statistically significant difference(P<0.05).(3) For image findings, the both groups were frequently found to have multiple lung-field involvement and bronchiectasis. The two group did not differ significantly in number of the cases with>four lung-field involvement and the overall number of cavities(P>0.05). Conclusion:Clinically common lung infections with MAIC and MCAC are mainly characterized by respiratory symptoms and malnutrition. Structural lung destruction characterized by multiple lung-field involvement and cavitation, as well as impaired cellular immune may result from long-term recurrent bronchiectasis and the pathogenic effect of NTM infection.
[1] 中华医学会结核病学分会.非结核分枝杆菌病实验室诊断专家共识.中华结核和呼吸杂志,2016,39(6):438-443.
[2] 中华医学会结核病学分会.分枝杆菌菌种中文译名原则专家共识.中华结核和呼吸杂志,2018,41(7):522-527.
[3] Kim J,seong MW,Kim EC,et al.Frequency and clinical im-plications of the isolation of rare nontuberculous mycobacteria[J].BMC Infect Dis,2015,15(1):9.
[4] 童莉谭守勇刘志辉.广州市越秀区及海珠区非结核分枝杆菌流行状况.实用医学杂志,2015,31(13):2211-2213.
[5] 王春花,庞学文,傅衍勇.非结核分枝杆菌相关研究新进展.结核病与肺部健康杂志,2015,4(1):61-65.
[6] 王桂荣,魏国梅,黄明翔,等.鸟分枝杆菌临床分离株亚种组成及耐药谱研究.结核病与肺部健康杂志,2017,6(2):114-117.
[7] 初乃惠.应重视非结核分枝杆菌病的诊治.中国医刊,2016,51(3):225-226.
[8] 沙巍.重视非结核分枝杆菌病的规范化诊治.中国防痨杂志,2017,39(3):217-219.
[9] 何贵清,金嘉琳,孙华平,等.呼吸道非结核分枝杆菌分离株的临床意义.中华传染病杂志,2018,36(4):206-212.
[10] Theerawit P,Vongsoasup A,Kiatboonsfi S.Identifying non-tuberculous Mycobaeterium lung diseases in acid-fast bacilli positive patients.Southeast Asian J Trop Med Public Health,2010,41(6):1432-1437.
[11] 张亚楠,段鸿飞.鸟-胞内分枝杆菌复合群肺病的诊断和治疗进展.中国防痨杂志2017,39(10)1126-1129.
[12] 江万航,刘国标、杜正新.免疫支持对非结核分枝杆菌肺病患者疗效影响.广州医药,2017,48(2):17-19.13 谭守勇、黎燕琼.耐多药结核病营养支持治疗.中国防痨杂志,2015,37(11):1164-1166.
[14] 王维勇,陈品儒,何间红,等.外周血T淋巴细胞与NTM肺病发病类型的相关性.广州医科大学学报,2017,45(2):90-93.
[15] 陈华,陈品儒,苏铎华,等.非结核分枝杆菌分布特点与耐药性分析.中华医院感染学杂志,2012,22(23):5419-5421.
[16] 王淑琦,姜广路,魏国梅,等.胞内分枝杆菌临床分离株耐药谱及基因型特征研究.中华结核和呼吸杂志,2018,41(7):539-543.
基本信息:
中图分类号:R563
引用信息:
[1]陈品儒,陈华,王维勇.两种常见非结核分枝杆菌肺病的临床特点分析[J].广州医科大学学报,2019,47(03):22-25+29.
基金信息:
广州市医药卫生科技项目(20141A011039);; 广东省医学科学研究项目(A2014576)